Biotech companies are racing to find Ozempic 2.0, hoping for a slice of a multi-billion-dollar industry. A few stand-out drugs are emerging.

Today there are more options than ever for managing migraine effectively. Find out what might work for you with this comprehensive guide to acute and preventive prescription drugs.

The FDA has approved Nerivio REN to include the acute and/or preventive treatment of migraine in patients 8 years of age and older.

Trace Neuroscience, which launched this week with $101 million, benefited from last year’s approval of Qalsody. Its CEO spoke ...

Research that was carried out by Baylor College of Medicine and Texas Children's Hospital doctors has led to the U.S. Food ...

A multitude of genes have been linked to the development of Alzheimer's disease. Specifically how those genes might influence ...

Tonix Pharmaceuticals (NASDAQ: TNXP) through its subsidiary Tonix Medicines, has introduced two fast-acting migraine treatments, Zembrace® SymTouch ...

The European Union's drugs regulator on Thursday recommended approval of Eisai and Biogen's Leqembi for some patients with ...

Theranica, a prescribed neuromodulation therapeutics company, today announced the Nerivio® REN wearable received an expanded age indication from the FDA for use in patients aged eight and above, ...

"Non-oral migraine medications, such as injectables and nasal sprays, do not rely on the digestive system to be absorbed and can offer the potential for faster relief from migraine symptoms in as ...

Total 3Q 2024 net product revenue of $104.8 million, representing 81% year-over-year growthAuvelity® 3Q 2024 net product sales of $80.4 million, ...

Recent developments driving growth in this area make the advanced, AI-supported digitization of pharma pipelines inevitable.